Stay updated on Cabozantinib for PN in NF1: Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for PN in NF1: Clinical Trial page.

Latest updates to the Cabozantinib for PN in NF1: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPubMed-related notes in the Publications and Deletions sections were updated, adding Revision: v3.3.2 for additions and Revision: v3.2.0 for deletions.SummaryDifference0.1%

- Check19 days agoChange DetectedA notice about a lapse in government funding and potential delays was removed from the page; core trial details such as eligibility, endpoints, and locations remain unchanged.SummaryDifference0.3%

- Check34 days agoChange DetectedThe changes are limited to formatting and wording updates on the Study Details page, with no changes to study design, endpoints, eligibility criteria, or enrollment figures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference2%

- Check69 days agoChange DetectedThe page now shows Revision: v3.1.0 replacing Revision: v3.0.2. This is a version update to the core page metadata.SummaryDifference0.0%

- Check84 days agoChange DetectedNo substantive content changes. The page now shows Revision: v3.0.2 and removes the 'Back to Top' element, indicating a minor UI update.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for PN in NF1: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for PN in NF1: Clinical Trial page.